ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors.

Yue Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.